๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Early-stage HER2+ Breast Cancer

Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site๐Ÿ“ Buenos Aires Oncoliq US Inc ยท Tests: Peripheral blood draw Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer NCT07593976Phase 21 site๐Ÿ“ Rouen Centre Henri Becquerel ยท Tests: [68Ga]Ga-NOTA-anti-HER2-sdAb Positron Emission Tomography ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NCT07084558NA14 sites๐Ÿ“ Vienna๐Ÿ“ Baden๐Ÿ“ Dornbirn Austrian Breast & Colorectal Cancer Study Group ยท Tests: blood sample for Signatera (TM) test, biopsy for Ki-67 assessment, FFPE tumor sample for Signatera (TM) test (archived) Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation NCT05761470Phase 21 site๐Ÿ“ Guangzhou Ying Lin ยท Tests: Camrelizumab, Fluzoparib, Nab-paclitaxel Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC NCT07797218Phase 31 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Docetaxel, Pyrotinib, Trastuzumab (Herceptin), Pertuzumab Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer NCT05306041Phase 262 sites๐Ÿ“ Essen๐Ÿ“ Augsburg๐Ÿ“ Berlin GBG Forschungs GmbH ยท Tests: Inavolisib, PHESGO, Endocrine therapy A Study of the TheraBionic P1 Device in Breast Cancer NCT07218432NA8 sites๐Ÿ“ Clarkston๐Ÿ“ Detroit๐Ÿ“ Farmington Hills Barbara Ann Karmanos Cancer Institute ยท Tests: TheraBionic P1 Device Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214EARLY Phase 11 site๐Ÿ“ Stony Brook Alison Stopeck ยท Tests: CEDM, CEDBT, Omnipaque 350mgI/mL Solution for Injection Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy NCT05989347Phase 11 site๐Ÿ“ New Haven Yale University ยท Tests: Dapagliflozin 10mg A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer NCT06508216Phase 1, Phase 21 site๐Ÿ“ Villejuif Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Dato-DXd, Durvalumab Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib NCT07237256Phase 3138 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Argenteuil UNICANCER ยท Tests: Chemotherapy followed by endocrine therapy and ribociclib treatment, De-escalation A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization NCT07527741n/a10 sites๐Ÿ“ Loznica๐Ÿ“ Poลพarevac๐Ÿ“ Bor Hoffmann-La Roche Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer NCT07340398Phase 21 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Nab paclitaxel, Carboplatin, Trastuzumab, Pertuzumab, SHR-A1811 RADIANT: Pre-op Radiation With Abemaciclib and Letrozole NCT06139107Phase 14 sites๐Ÿ“ Belleville๐Ÿ“ Livingston๐Ÿ“ New Brunswick Mridula George, MD ยท Tests: Abemaciclib, Letrozole Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab NCT05760612Phase 31 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Trastuzumab and neratinib, Trastuzumab and Pertuzumab Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) NCT06797635Phase 217 sites๐Ÿ“ Santa Monica๐Ÿ“ Skokie๐Ÿ“ Billings Merck Sharp & Dohme LLC ยท Tests: Patritumab deruxtecan, Pembrolizumab, Paclitaxel, Carboplatin, Doxorubicin hydrochloride Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer NCT04553770Phase 29 sites๐Ÿ“ Fullerton๐Ÿ“ Los Alamitos๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Anastrozole, Therapeutic Conventional Surgery, Trastuzumab Deruxtecan Neoadjuvant SNF Precision Therapy Phase III NCT06913777Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Targeted therapy agents: SNF2 -adebrelimab + famitinib; SNF3 -fluzoparib; SNF4 -apatinib, Chemotherapy (wP-EC) Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer NCT07057427Phase 31 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: Nab paclitaxel, Docetaxel and Carboplatin, Trastuzumab + Pertuzumab Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX NCT06723990n/a1 site๐Ÿ“ Milan European Institute of Oncology ยท Tests: Neoadjuvant standard treatment for HER2+, Adjuvant standard treatment for HER2+ Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women NCT03201861Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Paclitaxel, Cisplatin, EC to docetaxel or paclitaxel Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer NCT07630402NA1 site๐Ÿ“ Rochester University of Rochester ยท Tests: Echocardiogram EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase NCT06894173n/a29 sites๐Ÿ“ Aviano๐Ÿ“ Ancona๐Ÿ“ Avellino Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer NCT06001086Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Disitamb Vedotin ,pyrotinib NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline NCT06452394Phase 28 sites๐Ÿ“ Sankt Gallen๐Ÿ“ Genolier๐Ÿ“ Winterthur Swiss Cancer Institute ยท Tests: Doxycyclin Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial NCT07407920Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Biospecimen Collection, Hormone Therapy, Pembrolizumab, Pertuzumab, Trastuzumab Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy NCT07400523Phase 34 sites๐Ÿ“ Zhanjiang๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Ribociclib plus aromatase inhibitor, Aromatase inhibitor A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence NCT06492616Phase 3567 sites๐Ÿ“ Daphne๐Ÿ“ Chandler๐Ÿ“ Gilbert Stemline Therapeutics, Inc. ยท Tests: Elacestrant, Anastrozole, Letrozole, Exemestane, Tamoxifen Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer NCT06472583Phase 21 site๐Ÿ“ Gliwice Maria Sklodowska-Curie National Research Institute of Oncolโ€ฆ ยท Tests: Keytruda, Preoperative radiation therapy, Placebo Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted NCT05559164Phase 210 sites๐Ÿ“ Elizabeth๐Ÿ“ Hamilton๐Ÿ“ Jersey City Rutgers, The State University of New Jersey ยท Tests: Lipitor 40mg Tablet
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy